Baylor College of Medicine
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Baylor College of Medicine sits in the top decile of US sponsors by registered trial count (#56 of 15,742 sponsors by registered trial count).
Baylor College of Medicine: 616 sponsored US clinical trials, 93 recruiting.
Baylor College of Medicine sponsors 616 registered US clinical trials on ClinicalTrials.gov, 93 of them currently recruiting, and 376 completed. 59 of these trials are in Phase 3-4 (later-stage) and 232 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Non-Hodgkin Lymphoma, with 7 trials.
Top-decile sponsor footprint
Baylor College of Medicine ranks in the top decile of sponsors by registered trial count (#56 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
376 of 452 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (83.2%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
616 total, page 1 of 13
Novel Unedited Allo Cell Therapy For High Risk T-Cell Malignancies Using CD7-Specific Car T Cells
NCT07220993
Topical Steroids to Prevent Recurrent Urinary Tract Infections in Uncircumcised Male Infants: a Pilot Study
NCT07508124
Diagnostic Stewardship Intervention to Reduce Inappropriate Antibiotic Use for Urinary Tract Infections in Primary Care
NCT07246837
Clinical Outcomes, Safety, and Effectiveness of Speedboat UltraSlim™ in Per-Oral Endoscopic Myotomy (POEM)
NCT07496840
Transcutaneous Vagus Nerve Stimulation for Attention and Memory
NCT06723743
Genetic Study to Determine the Cause of Birth Defects in Newborns in Texas
NCT07102966
Constitutive IL7R (C7R) Modified Banked Allogeneic CD30.CAR EBVSTS for CD30-Positive Lymphomas
NCT06176690
GPC-3 CAR T CELLS FOR Recurrent GPC-3 Positive Glioblastoma
NCT06815432
Neonatal Neurodevelopmental Outcomes
NCT07101757
Clinical Evaluation of Montelukast in Veterans With Gulf War Illness
NCT05992311
Novel Brain Stimulation Treatment for Neuropsychiatric Symptoms in Alzheimer's Disease
NCT06835283
Comparative Effectiveness of Internet-based Versus Parent-Coached Cognitive-Behavioral Therapy For Children and Adolescents With Anxiety and OCD
NCT07024758
Cooking HEalthy and Facilitating Early Childhood Development: CHEF-ED Study
NCT06940817
Phase II Open-label Trial of Neoadjuvant Immunochemotherapy for Resectable Non-metastatic Colon cancER: NICER
NCT05870800
Immunotherapy For Adults With GPC3-Positive Solid Tumors Using IL-15 and IL-21 Armored GPC3-CAR T Cells
NCT06198296
The HIEnome Study: Genome Sequencing for Perinatal HIE
NCT06762795
Effect of Increased Physical Activity and Stopping Evening Snacking in Metabolic Health in Youth With Prediabetes
NCT06782906
PATHS-UP Health Behavior Self-monitoring Mobile App for Adolescents
NCT06959901
Adapting and Assessing the Feasibility of a Telehealth Diabetes Prevention Program for Hispanic Adolescents
NCT06943001
Rethinking Rigidity: Development of a 3D-Printed Scoliosis Brace With Varying Flexibility
NCT06785207
The Effect of Uterine Entry In Fetoscopic Laser Photocoagulation for Twin-To-Twin Transfusion Syndrome
NCT06829901
Neurophysiological Investigation of the Approach-avoidance Axis in OCD: Applications to Neuromodulation
NCT06596447
Effectiveness and Performance of an Optical Biopsy Technology for Esophageal Cancer in Brazil and the United States
NCT06435286
State-Funded Trial Assessing Recovery and Long-Term Impact of Guided Psilocybin for Healing Trauma
NCT06888128
SCREENS: Sleep, Circadian Rhythms, and Electronics in the EveNing Study
NCT06192745
Intrathecal Baclofen and Pediatric Dystonia
NCT06606574
Internet-delivered Cognitive-Behavioral Therapy for Adolescents With Autism and Anxiety
NCT06537128
EMPoWER Study - Strengths-based Behavioral Intervention for Youth With Type 1 Diabetes
NCT06014879
Novel Bipolar Radiofrequency Ablation Knife in Esophageal Lesions
NCT06476678
Superior Hypogastric Nerve Plexus Block With Bupivacaine After Robotic Resection of Endometriosis
NCT06577233
HPV Vaccine, Imiquimod, and Metformin Combination Trial
NCT06686043
Neoadjuvant Durvalumab and Tremelimumab With and Without Chemotherapy for Mesothelioma
NCT05932199
Novel Rigidizing Overtube in Colonic Endoscopic Submucosal Dissection
NCT06134687
Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors
NCT04715191
Heart Coherence Training on Vascular Ehlers-Danlos Syndrome Patients
NCT05994664
Clinical and Molecular Biomarker Studies in RAI1 (Retinoic Acid-Induced 1) -Related Disorders
NCT06274164
Growth Hormone Replacement in Veterans With GWI and AGHD (GWIT)
NCT05355272
Telehealth Behavioral Activation for Teens
NCT06273995
Integrating Food Rx With Best Feeding Practices With EFNEP
NCT05881759
Traction vs. No Traction in Colonic ESD
NCT06159634
Fetal Repair of Complex Gastroschisis: A Safety and Feasibility Trial
NCT05704257
Survivorship Care for Women Living With Ovarian Cancer: (POSTCARE-O)
NCT05752448
Enhancing Psychotherapy for Veterans and Service Members With PTSD and Anxiety
NCT05843695
Left vs Left Randomized Clinical Trial
NCT05650658
Marfan Syndrome Moderate Exercise Trial II
NCT05809323
Trivalent CAR-T Cell in Acute B-Lineage Leukemia (TRICAR-ALL)
NCT05010564
EVD Drainage Data and Intracranial Pressure (ICP) Measurements
NCT05546996
Intracranial Investigation of Neural Circuity Underlying Human Mood
NCT05871372
Baylor Infant and Toddler Biomarker of Nutrition Study
NCT05869760
The Goodnight Screen Media Study
NCT05820555
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 173 |
| Phase 2 | 59 |
| Phase 3 | 13 |
| Phase 4 | 46 |
Therapeutic Areas
What is open in the Baylor College of Medicine pipeline
93 recruiting of 616 indexed (15% open); 376 completed (61%).
Phase mix: 59 late (III/IV) vs 232 early (I/II) (early-phase heavy).
Top condition: Non-Hodgkin Lymphoma (7 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Baylor College of Medicine: open-pipeline peers nationwide
Peers matched on 616 registered trials and 15% open enrollment, not the therapeutic-area sidebar.
Baylor College of Medicine sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 616 trials (± recruiting share)
- University of Southern California · 617 trials · 16% recruiting
- US Department of Veterans Affairs · 632 trials · 0% recruiting
- University of Rochester · 636 trials · 15% recruiting
- Janssen Research & Development · 593 trials · 11% recruiting
Sponsors near 15% open enrollment (± trial volume)
- Stanford University · 15% recruiting · 1,744 trials
- Baylor University · 15% recruiting · 33 trials
- Cornell University · 15% recruiting · 66 trials
- 59th Medical Wing · 15% recruiting · 20 trials
Related
What to do with this Baylor College of Medicine page
616 registered trials is a research-attention snapshot, not an endorsement of Baylor College of Medicine or any single study.
- 93 of Baylor College of Medicine's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Non-Hodgkin Lymphoma is the condition Baylor College of Medicine studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Non-Hodgkin Lymphoma trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Baylor College of Medicine pipeline card: 616 registered trials from official public datasets.Report a data error.